Add office photos
Employer?
Claim Account for FREE
Roche Diagnostics
3.8
based on 230 Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Roche Diagnostics
Company Summary
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland.
Overall Rating
3.8/5
based on 230 reviews
3% below
industry average
Highly rated for
Salary
Critically rated for
Promotions, Job security
Work Policy
Hybrid
62% employees reported
Monday to Friday
54% employees reported
Flexible timing
78% employees reported
Within country
37% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
19 employees reported
Job/Soft skill training
17 employees reported
Cafeteria
8 employees reported
Professional degree assistance
5 employees reported
View all benefits
About Roche Diagnostics
Founded in1896 (129 yrs old)
India Employee Count201-500
Global Employee Count50k-1 Lakh
HeadquartersBasel,Basel City, Switzerland
Office Locations
--
Websiteroche.com
Primary Industry
Other Industries
Are you managing Roche Diagnostics's employer brand? To edit company information,
claim this page for free
View in video summary
F. Hoffmann-La Roche AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Mission: Doing now what patients need next
Managing your company's employer brand?
Claim this Company Page for FREE
Roche Diagnostics Ratings
based on 230 reviews
Overall Rating
3.8/5
How AmbitionBox ratings work?
5
98
4
63
3
27
2
14
1
28
Category Ratings
3.9
Salary
3.6
Company culture
3.6
Work-life balance
3.5
Skill development
3.5
Work satisfaction
3.3
Job security
3.2
Promotions
Roche Diagnostics is rated 3.8 out of 5 stars on AmbitionBox, based on 230 company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Roche Diagnostics
based on 213 reviews
4.1
Rated by 38 Women
Rated 3.9 for Work-life balance and 3.9 for Company culture
3.7
Rated by 175 Men
Rated 4.0 for Salary and 3.5 for Work-life balance
Work Policy at Roche Diagnostics
based on 21 reviews in last 6 months
Hybrid
62%
Work from office
29%
Permanent work from home
9%
Roche Diagnostics Reviews
Top mentions in Roche Diagnostics Reviews
+ 5 more
Compare Roche Diagnostics with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.8/5 based on 230 reviews | 4.1/5 based on 3k reviews | 3.9/5 based on 825 reviews | 4.0/5 based on 423 reviews |
Highly Rated for | Salary | Skill development Work-life balance Salary | Job security Work-life balance Company culture | Job security Work-life balance Company culture |
Critically Rated for | Promotions Job security | Promotions | Promotions | Promotions |
Primary Work Policy | Hybrid 62% employees reported | Work from office 50% employees reported | Hybrid 43% employees reported | Hybrid 89% employees reported |
Rating by Women Employees | 4.1 Good rated by 38 women | 4.1 Good rated by 386 women | 4.0 Good rated by 232 women | 3.9 Good rated by 82 women |
Rating by Men Employees | 3.7 Good rated by 175 men | 4.2 Good rated by 2.5k men | 3.8 Good rated by 546 men | 4.1 Good rated by 312 men |
Job security | 3.3 Average | 3.8 Good | 3.9 Good | 4.3 Good |
View more
Roche Diagnostics Salaries
Roche Diagnostics salaries have received with an average score of 3.9 out of 5 by 230 employees.
Zonal Manager
(29 salaries)
Unlock
₹13.2 L/yr - ₹26 L/yr
Senior Analyst
(25 salaries)
Unlock
₹9 L/yr - ₹19.1 L/yr
Analyst
(24 salaries)
Unlock
₹5.7 L/yr - ₹10.5 L/yr
Area Sales Manager
(19 salaries)
Unlock
₹11 L/yr - ₹16 L/yr
Territory Manager
(18 salaries)
Unlock
₹6 L/yr - ₹11 L/yr
Data Analyst
(18 salaries)
Unlock
₹3.5 L/yr - ₹9.4 L/yr
Service Engineer
(17 salaries)
Unlock
₹3.6 L/yr - ₹9.9 L/yr
Regional Manager
(17 salaries)
Unlock
₹16 L/yr - ₹40 L/yr
Sales Executive
(14 salaries)
Unlock
₹3.3 L/yr - ₹8.3 L/yr
Zonal Sales Manager
(12 salaries)
Unlock
₹18 L/yr - ₹22.8 L/yr
Roche Diagnostics Interview Questions
Interview questions by designation
Top Roche Diagnostics interview questions and answers
Get interview-ready with top interview questions
Roche Diagnostics News
View all
Healthcare AI Market to Surge 43% Annually—Key Stocks to Watch
- The healthcare AI market is experiencing rapid growth, with Conversational AI in Healthcare projected to reach $48.87 billion by 2030 driven by a 23.84% CAGR.
- Avant Technologies, Inc. is one of the key players in the industry, expanding its AI capabilities through a partnership with Ainnova Tech to focus on early disease detection using AI.
- The partnership aims to develop and commercialize Ainnova's Vision AI platform for detecting various diseases with high accuracy.
- Avant Technologies and Ainnova aim to obtain FDA clearance for their Vision AI platform, which could revolutionize early disease detection in the healthcare sector.
- Avant's collaboration with Roche in Costa Rica showcases its commitment to leveraging AI technology for real-world healthcare challenges like diabetic retinopathy detection.
- Other notable developments in the industry include Spectral AI's milestone in advancing its DeepView® System and Absci Corporation's partnership with Owkin in drug discovery.
- Schrödinger, Inc. reported strategic priorities for 2025 and expanded its research collaboration with Otsuka, while Medtronic plc gained FDA approval for BrainSense™ Adaptive deep brain stimulation for Parkinson's disease patients.
- The healthcare AI market continues to evolve rapidly, with companies focusing on innovative AI-driven solutions to enhance patient care and treatment outcomes.
- Investors are advised to conduct thorough research and consult with financial advisors before making any investment decisions in this dynamic and rapidly growing sector.
- The future of healthcare looks increasingly intertwined with AI technologies, offering promising advancements in disease detection, treatment, and patient care.
- As the industry continues to witness remarkable growth and advancements, AI-driven solutions are expected to play a pivotal role in shaping the future of healthcare.
Baystreet | 25 Feb, 2025
IIT Madras’ Centre for Responsible AI partners with Switzerland-based Roche Diagnostics for R&D
- IIT Madras’ Centre for Responsible AI (CeRAI) has partnered with Roche Diagnostics for research and development (R&D).
- CeRAI is a virtual interdisciplinary research centre at IIT Madras, focusing on Ethical and Responsible AI.
- Roche Diagnostics is a global provider of diagnostic solutions for healthcare professionals and patients.
- The collaboration aims to conduct research on Analytics and AI in digital health solutions for in-vitro diagnostics, with a focus on developing ethical frameworks.
HinduBusinessLine | 14 Feb, 2025
AI in Healthcare Sees Explosive Growth: Key Innovations Investors Should Watch
- According to a recent Deloitte survey, 40% of healthcare executives report that generative AI (genAI) is already delivering tangible benefits for their businesses.
- Emerging innovators are making significant strides in AI-driven healthcare solutions.
- Avant Technologies, Inc. and its partner Ainnova develop AI medical technology.
- Analysts at BCC Research forecast that the AI Revolutionizing Industries Market will experience a 39.7% CAGR, reaching an estimated $1.1 trillion by 2029.
- Research from SNS Insider projects that the Generative AI in Healthcare Market is set to skyrocket to $19.99 billion by 2032, growing at a robust 31.5% CAGR.
- Avant Technologies, Inc. is an emerging leader in AI-driven healthcare innovation.
- Avant Technologies has announced a game-changing collaboration with pharma giant Roche.
- Avant and Ainnova are advancing and commercializing Ainnova’s technology portfolio, including its Vision AI platform.
- VSee Health, Inc. recently announced the successful renewal of a $2 million, two-year contract with a top 50 IDN hospital system.
- ICAD, Inc. presented four novel AI-driven breast cancer research abstracts in December.
Baystreet | 11 Feb, 2025
Metropolis, Roche Diagnostics partner to bring self-sampling HPV test for cervical cancer
- Metropolis and Roche Diagnostics have partnered to bring a self-sampling HPV test for cervical cancer.
- The test detects 14 high-risk HPV types in a single tube and is clinically validated, FDA-approved, and WHO-prequalified.
- The self-sampling test allows women to collect their samples for testing at home, making screening more accessible and patient-friendly.
- Cervical cancer is preventable, yet it remains a major health challenge in India. The new test aims to expand access to early detection across the country.
HinduBusinessLine | 4 Feb, 2025
Union Budget 2025: Cancer medicines and patient assistance programmes come in for reprieve
- Medicines from multinational companies, including Pembrolizumab (MSD Pharma), Lorlatinib (Pfizer), Ribociclib (Novartis), Selumetinib (Astra Zeneca), Teclistamab (Johnson & Johnson), Cetuximab (Merck Specialities), Brentuximab Vedotin (Takeda); Mepolizumab (GSK Pharma), Risdiplam Powder (Roche), Luspatercept (Bristol Myers Squibb) are among the 37 listed to get Basic Customs Duty exemptions, provided they are given free.
- Additionally, the budget proposes to add 13 new patient assistance programs for supplying medicines free of cost to patients.
- 36 lifesaving drugs and medicines will be added to the list of medicines fully exempted from Basic Customs Duty (BCD), and 6 lifesaving medicines will be eligible for concessional customs duty of 5 percent.
- The budget also plans to establish 200 daycare cancer centers in all district hospitals in the next three years.
HinduBusinessLine | 1 Feb, 2025
Roche CEO Thomas Schinecker named IFPMA’s new President
- Roche CEO Thomas Schinecker has been named as the new President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
- He will be joined by Rob Davis, Chief Executive of MSD, as the newly appointed Vice-President.
- Dr Schinecker expressed his commitment to championing forward-thinking policies, impactful partnerships, and pioneering innovations in the pharmaceutical industry.
- The outgoing IFPMA President, Dr Albert Bourla, highlighted the importance of innovative medicines and vaccines in the current healthcare landscape.
HinduBusinessLine | 27 Nov, 2024
Rare diseases patient representatives seek govt intervention to access treatment
- Rare diseases patient representatives are seeking government intervention to access treatment for conditions such as spinal muscular atrophy (SMA) and cystic fibrosis (CF).
- Roche, the maker of Risdiplam used to treat SMA, is seeking a permanent injunction against Natco Pharma from producing a generic version of the drug, hindering access to affordable options.
- Activists highlight the need for a coordinated treatment framework and express concerns about high drug costs and limited access in SMA cases.
- Cystic fibrosis patients in India face barriers due to patent restrictions, as the necessary drug has not been registered with Indian regulatory authorities.
HinduBusinessLine | 5 Nov, 2024
Powered by
Roche Diagnostics Subsidiaries
Viewics
2.3
• 5 reviews
Genentech
5.0
• 2 reviews
Report error
Compare Roche Diagnostics with
Beckman Coulter
3.7
Becton Dickinson
4.0
Sysmex
3.7
Bio-Rad Laboratories
3.5
Agilent Technologies
4.1
PerkinElmer
4.2
Sanofi
4.2
AstraZeneca
4.1
Apotex Research
4.1
Otsuka Pharmaceutical India Private Limited
4.1
Novartis Healthcare
4.1
Merck
4.3
Apcer Life Sciences
3.8
Boehringer-Ingelheim
3.9
MSD Pharmaceuticals
4.1
Modi Mundi Pharma
3.6
Vertex
3.8
Eversana
3.6
Adcock Ingram
3.6
VWR International
3.6
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Roche Diagnostics
Siemens Healthineers
Healthcare
4.0
• 423 reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3k reviews
Thermo Fisher Scientific
Biotech & Life sciences, Internet, Analytics & KPO, Biotechnology, Pharma
3.9
• 825 reviews
Beckman Coulter
Manufacturing, Medical Equipment
3.7
• 145 reviews
Becton Dickinson
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Medical Equipment
4.0
• 487 reviews
Sysmex
Healthcare / Pharma, Internet
3.7
• 41 reviews
Bio-Rad Laboratories
Biotech & Life sciences, Internet
3.5
• 49 reviews
Agilent Technologies
Biotech & Life sciences, Pharma
4.1
• 330 reviews
PerkinElmer
Internet, Pharma
4.2
• 136 reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.2k reviews
AstraZeneca
Biotechnology, Pharma
4.1
• 829 reviews
Apotex Research
Analytics & KPO, Pharma
4.1
• 787 reviews
Roche Diagnostics FAQs
When was Roche Diagnostics founded?
Roche Diagnostics was founded in 1896. The company has been operating for 129 years primarily in the Pharma sector.
Where is the Roche Diagnostics headquarters located?
Roche Diagnostics is headquartered in Basel,Basel City.
How many employees does Roche Diagnostics have in India?
Roche Diagnostics currently has more than 200+ employees in India. Sales & Business Development department appears to have the highest employee count in Roche Diagnostics based on the number of reviews submitted on AmbitionBox.
Does Roche Diagnostics have good work-life balance?
Roche Diagnostics has a Work-Life Balance Rating of 3.6 out of 5 based on 200+ employee reviews on AmbitionBox. 70% employees rated Roche Diagnostics 4 or above, while 30% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Roche Diagnostics work-life balance reviews for more details
Is Roche Diagnostics good for career growth?
Career growth at Roche Diagnostics is rated as moderate, with a promotions and appraisal rating of 3.2. 30% employees rated Roche Diagnostics 3 or below, while 70% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Roche Diagnostics promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Roche Diagnostics?
Working at Roche Diagnostics comes with several advantages and disadvantages. It is highly rated for salary & benefits. However, it is poorly rated for promotions / appraisal and job security, based on 200+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
